Showing results (171-180 of 234) with videos related to

Sort By:
Pageof 24
Circulation|July 6, 2006
Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat heartsIngo Kutschka, Ian Y Chen, Theo Kofidis, et al.
Journal of the American Chemical Society|October 12, 2021
Implications of the Conformationally Flexible, Macrocyclic Structure of the First-Generation, Direct-Acting Anti-Viral Paritaprevir on Its Solid Form Complexity and Chameleonic BehaviorAhmad Y Sheikh, Alessandra Mattei, Rajni Miglani Bhardwaj, et al.
Nano Letters|October 29, 2021
Angstrom-Scale Transparent Overcoats: Interfacial Nitrogen-Driven Atomic Intermingling Promotes Lubricity and Surface Protection of Ultrathin CarbonNeeraj Dwivedi, Arnab Neogi, Tarak K Patra, et al.
Circulation|July 6, 2006
Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat heartsIngo Kutschka, Theo Kofidis, Ian Y Chen, et al.
The New England Journal of Medicine|March 26, 2010
Rifaximin treatment in hepatic encephalopathyNathan M Bass, Kevin D Mullen, Arun Sanyal, et al.
The Journal of Clinical Investigation|September 5, 2008
Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosisHyung J Chun, Ziad A Ali, Yoko Kojima, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 22, 2009
Endogenous regulation of cardiovascular function by apelin-APJDavid N Charo, Michael Ho, Giovanni Fajardo, et al.
Gastrointestinal Endoscopy|December 5, 2006
The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosisArun J Sanyal, Robert J Fontana, Adrian M Di Bisceglie, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 29, 2011
In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardiumAhmad Y Sheikh, Bruno C Huber, Kazim H Narsinh, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitisVlad Ratziu, Muhammad Y Sheikh, Arun J Sanyal, et al.
Pageof 24